Tech Company Financing Transactions
Heranova Lifesciences Funding Round
On 12/28/2023, Heranova Lifesciences raised $13.5 million in Seed funding from Emerging Technology Partners, Pivotal bioVenture Partners and Sinovation Ventures.
Transaction Overview
Company Name
Announced On
12/28/2023
Transaction Type
Venture Equity
Amount
$13,500,000
Round
Seed
Proceeds Purpose
This funding will be used to launch a serial of non-invasive endometriosis tests and advance two innovative (non-hormonal and non-antibiotic) therapeutic programs for endometriosis and bacterial vaginosis.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
2 Burlington Woods Dr 100
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
Heranova is a global Women's Health company dedicated to addressing unmet medical needs in women. The current state of women's healthcare is far from acceptable, with many health needs largely ignored. We are committed to addressing these unmet healthcare needs throughout a woman's life, including reproductive health, pregnancy, and menopause.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Zhao
Chief Medical Officer
Farideh Bischoff
Co-Founder
Steve Landau
Co-Founder
Penny Wan
Co-Founder
Chun Zhang
Browse more venture capital transactions:
Prev: 12/28/2023: Fasal venture capital transaction
Next: 12/29/2023: Devoted Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs